Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4099 results

Sort By:

Vitamin C for Acute Kidney Injury in ACLF With Septic Shock: A Randomized Controlled Trial

Study ID: NCT07184866
Start Date: 2026-04
End Date: 2027-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

110

Intervention / Treatment

Vitamin C

Standard of Care (SOC)

Sponsor

Institute of Liver and Biliary Sciences, India

Source: clinicaltrials.gov

Share:
Add to list

Cognitive Strategies in Early Psychosis 2

Study ID: NCT07263022
Start Date: 2026-04-13
End Date: 2030-04-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

24

Intervention / Treatment

Modafinil

D-serine solution

Placebo

Sponsor

University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients With Advanced or Metastatic Breast Cancer Resistant to Adjuvant Endocrine Therapy.

Study ID: NCT07354022
Start Date: 2026-12
End Date: 2031-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

912

Intervention / Treatment

HRS-8080 Tablet ; Dalpiciclib Isethionate

Fulvestrant injection ;Dalpiciclib Isethionate

Sponsor

Shandong Suncadia Medicine Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis

Study ID: NCT07006805
Start Date: 2026-06
End Date: 2029-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

12

Intervention / Treatment

CABA-201

Sponsor

Organic Cabaletta

Source: clinicaltrials.gov

Share:
Add to list

SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer

Study ID: NCT07464756
Start Date: 2026-04-05
End Date: 2030-07-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

SHR-1701

apatinib

S-1 & Oxaliplatin

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Source: clinicaltrials.gov

Share:
Add to list

Nebulized Ketamine Plus Standard Care vs. Standard Care Alone in Moderate to Severe Asthma Exacerbations

Study ID: NCT07112456
Start Date: 2026-09-01
End Date: 2029-08-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

Nebulized ketamine (0.5 mg/kg in normal saline to a total volume of 5ml) plus standard asthma excaerbationcare

Placebo nebulization (5 mL normal saline) plus standard asthma care

Sponsor

Oman Medical Speciality Board

Source: clinicaltrials.gov

Share:
Add to list

IL-17 Blockade to Decrease irAEs (REPLAY)

Study ID: NCT07237594
Start Date: 2026-05-01
End Date: 2030-06-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

4

Intervention / Treatment

Secukinumab Injection

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer

Study ID: NCT02448173
Start Date: 2026-08
End Date: 2033-08
Study Type

Interventional

Study Phase

Phase3

No. of Participants

550

Intervention / Treatment

OncoVAX and Surgery

Surgery

Sponsor

Vaccinogen Inc

Source: clinicaltrials.gov

Share:
Add to list

Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab

Study ID: NCT07039422
Start Date: 2026-04-27
End Date: 2030-08-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Ianalumab

Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Prognostic Value of (DHODH) Expression in (HGSOC): A Comparative Study Between Neoadjuvant and Adjuvant Chemotherapy Settings

Study ID: NCT07366242
Start Date: 2026-06-01
End Date: 2027-07-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

72

Intervention / Treatment

Immunohistochemical (IHC) assessment of DHODH expression

No interventions as it is observational study

Sponsor

Heba Ahmed Mohamed

Source: clinicaltrials.gov

Share:
Add to list